Exploring the role of cancer stem cells in radioresistance (original) (raw)

• Clarke, M. F. et al. Cancer stem cells — perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res. 66, 9339–9344 (2006).
  Article CAS PubMed Google Scholar
• Dingli, D. & Michor, F. Successful therapy must eradicate cancer stem cells. Stem Cells 24, 2603–2610 (2006).
  Article CAS PubMed Google Scholar
• Baumann, M., Dubois, W. & Suit, H. D. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiation Res. 123, 325–330 (1990).
  Article CAS PubMed Google Scholar
• Kummermehr, J. & Trott, K. R. in Stem cells (ed. Potten, C. S.) 363–400 (Academic Press Limited, London, 1997).
  Book Google Scholar
• Hill, R. P. & Milas, L. The proportion of stem cells in murine tumors. Int. J. Radiat. Oncol. Biol. Phys. 16, 513–518 (1989).
  Article CAS PubMed Google Scholar
• Trott, K. R. Tumour stem cells: the biological concept and its application in cancer treatment. Radiother. Oncol. 30, 1–5 (1994).
  Article CAS PubMed Google Scholar
• Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007).
  Article CAS PubMed Google Scholar
• Aoyama, H. et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int. J. Radiat. Oncol. Biol. Phys. 56, 793–800 (2003).
  Article PubMed Google Scholar
• Hof, H. et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 56, 335–341 (2003).
  Article PubMed Google Scholar
• Onimaru, R. et al. Steep dose–response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. (2007).
• Onishi, H. et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J. Thorac. Oncol. 2, S94–S100 (2007).
  Article PubMed Google Scholar
• Madsen, B. L. et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int. J. Radiat. Oncol. Biol. Phys. 67, 1099–1105 (2007).
  Article PubMed Google Scholar
• Bernier, J., Hall, E. J. & Giaccia, A. Radiation oncology: a century of achievements. Nature Rev. Cancer 4, 737–747 (2004).
  Article CAS Google Scholar
• Thames, H. D. & Hendry, J. H. Fractionation in Radiotherapy (Taylor and Francis, Philadelphia, 1987).
• Pusey, W. A. IX. The use of X-rays in carcinoma. Ann. Surg. 42, 910–917 (1905).
  Article CAS PubMed PubMed Central Google Scholar
• Walstam, R. in 1895-1995 Radiation Oncology, a Century of Progress and Achievements p17–46 (ESTRO, Leuven, 1995).
  Google Scholar
• Holthusen, H. Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlenther. 57, 254–269 (1936) (in German).
  Google Scholar
• Yaromina, A. et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother. Oncol. (2007).
• Gerweck, L. E., Zaidi, S. T. & Zietman, A. Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses. Int. J. Radiat. Oncol. Biol. Phys. 29, 57–66 (1994).
  Article CAS PubMed Google Scholar
• Taghian, A. et al. In vivo radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 32, 99–104 (1995).
  Article CAS PubMed Google Scholar
• Suit, H. D. et al. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report. Int. J. Radiat. Oncol. Biol. Phys. 18, 365–373 (1990).
  Article CAS PubMed Google Scholar
• Yaromina, A. et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: The need for a multivariate approach in biomarker studies. Radiother. Oncol. 81, 122–129 (2006).
  Article CAS PubMed Google Scholar
• Schreiber, A. et al. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. Strahlenther. Onkol. 180, 375–382 (2004).
  Article PubMed Google Scholar
• Kaanders, J. H. et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62, 7066–7074 (2002).
  CAS PubMed Google Scholar
• Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J. & Horsman, M. R. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol. 6, 757–764 (2005).
  Article CAS PubMed Google Scholar
• Thames, H. D. Jr, Withers, H. R., Peters, L. J. & Fletcher, G. H. Changes in early and late radiation responses with altered dose fractionation: implications for dose–survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8, 219–226 (1982).
  Article PubMed Google Scholar
• Petersen, C. et al. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int. J. Radiat. Oncol. Biol. Phys. 51, 483–493 (2001).
  Article CAS PubMed Google Scholar
• Williams, M. V., Denekamp, J. & Fowler, J. F. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int. J. Radiat. Oncol. Biol. Phys. 11, 87–96 (1985).
  Article CAS PubMed Google Scholar
• Petersen, C. et al. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC. Radiother. Oncol. 74, 331–336 (2005).
  Article PubMed Google Scholar
• Beck-Bornholdt, H. P., Omniczynski, M., Theis, E., Vogler, H. & Wurschmidt, F. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncol. 30, 57–63 (1991).
  Article CAS PubMed Google Scholar
• Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. & Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946–10951 (2005).
  Article CAS PubMed Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
  CAS PubMed Google Scholar
• Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65, 9328–9337 (2005).
  Article CAS PubMed Google Scholar
• Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973–978 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111–115 (2007).
  CAS PubMed Google Scholar
• Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L. & Strasser, A. Tumor growth need not be driven by rare cancer stem cells. Science 317, 337 (2007).
  Article CAS PubMed Google Scholar
• Hill, R. P. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res. 66, 1891–1895; discussion 1890 (2006).
  Article CAS PubMed Google Scholar
• Zheng, X., Shen, G., Yang, X. & Liu, W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 67, 3691–3697 (2007).
  Article CAS PubMed Google Scholar
• Calabrese, C. et al. A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69–82 (2007).
  Article CAS PubMed Google Scholar
• Wang, J. et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122, 761–768 (2008).
  Article CAS PubMed Google Scholar
• Jamieson, C. H. et al. Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657–667 (2004).
  Article CAS PubMed Google Scholar
• Maeda, S. et al. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br. J. Cancer 98, 1389–1397 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Florek, M. et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 319, 15–26 (2005).
  Article CAS PubMed Google Scholar
• Kennedy, J. A., Barabe, F., Poeppl, A. G., Wang, J. C. & Dick, J. E. Comment on “Tumor growth need not be driven by rare cancer stem cells”. Science 318, 1722; author reply 1722 (2007).
  Article CAS PubMed Google Scholar
• Barabe, F., Kennedy, J. A., Hope, K. J. & Dick, J. E. Modeling the initiation and progression of human acute leukemia in mice. Science 316, 600–604 (2007).
  Article CAS PubMed Google Scholar
• Hill, R. P. & Perris, R. “Destemming” cancer stem cells. J. Natl Cancer Inst. 99, 1435–1440 (2007).
  Article CAS PubMed Google Scholar
• Munro, T. R. & Gilbert, C. W. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br. J. Radiol. 34, 246–251 (1961).
  Article CAS PubMed Google Scholar
• Krause, M., Zips, D., Thames, H. D., Kummermehr, J. & Baumann, M. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiother. Oncol. 80, 112–122 (2006).
  Article CAS PubMed Google Scholar
• Hermans, A. F. & Barendsen, G. W. Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur. J. Cancer 5, 173–189 (1969).
  Article Google Scholar
• Hill, R. P., Bush, R. S. & Yeung, P. The effect of anaemia on the fraction of hypoxic cells in an experimental tumor. Br. J. Radiol. 44, 299–304 (1971).
  Article CAS PubMed Google Scholar
• Hewitt, H. B. & Wilson, C. W. Survival curves for tumor cells irradiated in vivo. Ann. NY Acad. Sci. 95, 818–827 (1961).
  Article CAS PubMed Google Scholar
• Stephens, T. C., Currie, G. A. & Peacock, J. H. Repopulation of γ-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br. J. Cancer 38, 573–582 (1978).
  Article CAS PubMed PubMed Central Google Scholar
• Suit, H., Shalek, R. & Wette, R. in Cellular Radiation Biology 514–530 (Williams and Wilkins, Baltimore, 1965).
• Dubben, H. H., Thames, H. D. & Beck-Bornholdt, H. P. Tumor volume: a basic and specific response predictor in radiotherapy [see comments]. Radiother. Oncol. 47, 167–174 (1998).
  Article CAS PubMed Google Scholar
• Bentzen, S. M. & Thames, H. D. Tumor volume and local control probability: clinical data and radiobiological interpretations [comment]. Int. J. Radiat. Oncol. Biol. Phys. 36, 247–251 (1996).
  Article CAS PubMed Google Scholar
• Johnson, C. R., Thames, H. D., Huang, D. T. & Schmidt-Ullrich, R. K. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 33, 281–287 (1995).
  Article CAS PubMed Google Scholar
• Malaise, E. P., Fertil, B., Chavaudra, N. & Guichard, M. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data. Int. J. Radiat. Oncol. Biol. Phys. 12, 617–624 (1986).
  Article CAS PubMed Google Scholar
• Deacon, J., Peckham, M. J. & Steel, G. G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother. Oncol. 2, 317–323 (1984).
  Article CAS PubMed Google Scholar
• Buffa, F. M., Davidson, S. E., Hunter, R. D., Nahum, A. E. & West, C. M. Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 50, 1113–1122 (2001).
  Article CAS PubMed Google Scholar
• West, C. M., Davidson, S. E., Roberts, S. A. & Hunter, R. D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 76, 1184–1190 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Budach, W. et al. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Res. 52, 6292–6296 (1992).
  CAS PubMed Google Scholar
• Gerweck, L. E., Vijayappa, S., Kurimasa, A., Ogawa, K. & Chen, D. J. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res. 66, 8352–8355 (2006).
  Article CAS PubMed Google Scholar
• Ogawa, K. et al. Influence of tumor cell and stroma sensitivity on tumor response to radiation. Cancer Res. 67, 4016–4021 (2007).
  Article CAS PubMed Google Scholar
• Kasten-Pisula, U. et al. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair. Radiother. Oncol. (in the press).
• Withers, H. R. in Advances in radiation biology (eds. Lett, J. T. & Adler, H.) 241–247 (Academic Press, New York, 1975).
  Google Scholar
• Steel, G. G., McMillan, T. J. & Peacock, J. H. The 5Rs of radiobiology. Int. J. Radiat. Biol. 56, 1045–8 (1989).
  Article CAS PubMed Google Scholar
• Beck-Bornholdt, H. P., Schmidt, R., Schwarz, R. C. & Hubener, K. H. Biological isoeffect distributions: consideration of the influence of dose per fraction and overall treatment time. A possible tool in future treatment planning. Strahlenther. Onkol. 167, 708–715 (1991).
  CAS PubMed Google Scholar
• Eramo, A. et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 13, 1238–1241 (2006).
  Article CAS PubMed Google Scholar
• Ghods, A. J. et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25, 1645–53 (2007).
  Article CAS PubMed Google Scholar
• Kang, M. K. & Kang, S. K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16, 837–847 (2007).
  Article CAS PubMed Google Scholar
• Liu, G. et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5, 67 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Ma, S., Lee, T. K., Zheng, B. J., Chan, K. W. & Guan, X. Y. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27, 1749–1758 (2008).
  Article CAS PubMed Google Scholar
• Mimeault, M., Hauke, R., Mehta, P. P. & Batra, S. K. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J. Cell. Mol. Med. 11, 981–1011 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Denekamp, J. Tumour stem cells: facts, interpretation and consequences. Radiother. Oncol. 30, 6–10 (1994).
  Article CAS PubMed Google Scholar
• Hendry, J. H., West, C. M., Moore, J. V. & Potten, C. S. Tumour stem cells: the relevance of predictive assays for tumour control after radiotherapy. Radiother. Oncol. 30, 11–16 (1994).
  Article CAS PubMed Google Scholar
• Lobrich, M. & Kiefer, J. Assessing the likelihood of severe side effects in radiotherapy. Int. J. Cancer 118, 2652–2656 (2006).
  Article CAS PubMed Google Scholar
• Akervall, J. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev. 24, 87–94 (2005).
  Article CAS PubMed Google Scholar
• Andreassen, C. N. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol. 44, 801–815 (2005).
  Article PubMed Google Scholar
• Eriksen, J. G. et al. Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother. Oncol. 72, 275–282 (2004).
  Article CAS PubMed Google Scholar
• Buffa, F. M. et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin. Cancer Res. 10, 3745–3754 (2004).
  Article CAS PubMed Google Scholar
• Bentzen, S. M. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 6, 112–117 (2005).
  Article PubMed Google Scholar
• Chao, K. S. et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 49, 1171–1182 (2001).
  Article CAS PubMed Google Scholar
• Nordsmark, M. et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother. Oncol. (2005).
• Kaanders, J. H. et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62, 7066–7074 (2002).
  CAS PubMed Google Scholar
• Eriksen, J. G., Alsner, J., Steiniche, T. & Overgaard, J. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. Radiother. Oncol. 76, 135–142 (2005).
  Article CAS PubMed Google Scholar
• Eriksen, J. G., Steiniche, T. & Overgaard, J. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother. Oncol. 74, 93–100 (2005).
  Article CAS PubMed Google Scholar
• Begg, A. C. et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother. Oncol. 50, 13–23 (1999).
  Article CAS PubMed Google Scholar
• Lee, C. M. et al. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol. Oncol. 99, 415–421 (2005).
  Article CAS PubMed Google Scholar
• Eriksen, J. G. & Overgaard, J. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Radiother. Oncol. 83, 383–388 (2007).
  Article CAS PubMed Google Scholar
• Hemmati, H. D. et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA 100, 15178–15183 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
  Article CAS PubMed Google Scholar
• Bao, S. et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843–7848 (2006).
  Article CAS PubMed Google Scholar
• Rich, J. N. Cancer stem cells in radiation resistance. Cancer Res. 67, 8980–8984 (2007).
  Article CAS PubMed Google Scholar
• Blazek, E. R., Foutch, J. L. & Maki, G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 67, 1–5 (2007).
  Article CAS PubMed Google Scholar
• Phillips, T. M., McBride, W. H. & Pajonk, F. The response of CD24−/low/CD44+ breast cancer-initiating cells to radiation. J. Natl Cancer Inst. 98, 1777–1785 (2006).
  Article PubMed Google Scholar
• Woodward, W. A. et al. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl Acad. Sci. USA 104, 618–623 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, M. S. et al. Wnt/ β-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J. Cell Sci. 120, 468–477 (2007).
  Article CAS PubMed Google Scholar
• Tannock, I. F. & Lee, C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br. J. Cancer 84, 100–105 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, J. M. & Attardi, L. D. The role of apoptosis in cancer development and treatment response. Nature Rev. Cancer 5, 231–237 (2005).
  Article Google Scholar
• Hambardzumyan, D., Squatrito, M. & Holland, E. C. Radiation resistance and stem-like cells in brain tumors. Cancer Cell 10, 454–456 (2006).
  Article CAS PubMed Google Scholar
• Ciampi, A., Kates, L., Buick, R., Kriukov, Y. & Till, J. E. Multi-type Galton–Watson process as a model for proliferating human tumour cell populations derived from stem cells: estimation of stem cell self-renewal probabilities in human ovarian carcinomas. Cell Tissue Kinet. 19, 129–140 (1986).
  CAS PubMed Google Scholar
• Diehn, M. & Clarke, M. F. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J. Natl Cancer Inst. 98, 1755–1757 (2006).
  Article PubMed Google Scholar
• Wright, E. A. & Howard-Flanders, P. The influence of oxygen on the radiosensitivity of mammalian tissues. Acta Radiologica 48, 26–32 (1957).
  Article CAS PubMed Google Scholar
• Gray, L. H., Conger, A. D., Ebert, M., Hornsay, S. & Scott, O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26, 638–648 (1953).
  Article CAS PubMed Google Scholar
• Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26, 225–239 (2007).
  Article CAS PubMed Google Scholar
• Overgaard, J. Hypoxic radiosensitization: adored and ignored. J. Clin. Oncol. 25, 4066–4074 (2007).
  Article PubMed Google Scholar
• Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. & Simon, M. C. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361–9374 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Covello, K. L. et al. HIF-2α regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20, 557–570 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gordan, J. D., Bertout, J. A., Hu, C. J., Diehl, J. A. & Simon, M. C. HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11, 335–347 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Gustafsson, M. V. et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9, 617–628 (2005).
  Article CAS PubMed Google Scholar
• Platet, N. et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett. 258, 286–290 (2007).
  Article CAS PubMed Google Scholar
• Quennet, V. et al. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiother. Oncol. 81, 130–135 (2006).
  Article CAS PubMed Google Scholar
• Ling, C. C. et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int. J. Radiat. Oncol. Biol. Phys. 47, 551–560 (2000).
  Article CAS PubMed Google Scholar
• Cordes, N., Seidler, J., Durzok, R., Geinitz, H. & Brakebusch, C. β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 25, 1378–1390 (2006).
  Article CAS PubMed Google Scholar
• Moore, K. A. & Lemischka, I. R. Stem cells and their niches. Science 311, 1880–1885 (2006).
  Article CAS PubMed Google Scholar
• Scadden, D. T. The stem-cell niche as an entity of action. Nature 441, 1075–1079 (2006).
  Article CAS PubMed Google Scholar
• Gilbertson, R. J. & Rich, J. N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nature Rev. Cancer 7, 733–736 (2007).
  Article CAS Google Scholar
• Hambardzumyan, D. et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 22, 436–48 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bonner, J. A. et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354, 567–578 (2006).
  Article CAS PubMed Google Scholar
• Pignon, J. P., Bourhis, J., Domenge, C. & Designe, L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355, 949–955 (2000).
  Article CAS PubMed Google Scholar
• Krause, M. et al. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: Differential response of cancer stem cells and nontumourigenic cells? Radiother. Oncol. 83, 316–325 (2007).
  Article CAS PubMed Google Scholar
• Baumann, M. et al. Selective inhibition of the epidermal growth factor tyrosine kinase by BIBX1382BS improves growth delay but not local control after fractionated irradiation in human FaDu squamous cell carcinoma in nude mice. Int. J. Radiat. Biol. 79, 1547–559 (2003).
  Google Scholar
• Zips, D. et al. Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation. Anticancer Res. 23, 3869–3876 (2003).
  CAS PubMed Google Scholar
• Zips, D. et al. Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice. Int. J. Radiat. Oncol. Biol. Phys. 61, 908–914 (2005).
  Article CAS PubMed Google Scholar
• Weppler, S. A. et al. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: Possible role for thrombosis. Radiother. Oncol. 82, 96–104 (2007).
  Article CAS PubMed Google Scholar
• Milas, L. et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin. Cancer Res. 6, 701–708 (2000).
  CAS PubMed Google Scholar
• Nasu, S., Ang, K. K., Fan, Z. & Milas, L. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int. J. Radiat. Oncol. Biol. Phys. 51, 474–477 (2001).
  Article CAS PubMed Google Scholar
• Krause, M. et al. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. Radiother. Oncol. 74, 109–115 (2005).
  Article CAS PubMed Google Scholar
• Kozin, S. V. et al. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res. 61, 39–44 (2001).
  CAS PubMed Google Scholar
• Bayer, C. et al. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother. Oncol. 86, 361–368 (2008).
  Article CAS PubMed Google Scholar
• Schutze, C. et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice. Radiother. Oncol. 83, 311–315 (2007).
  Article CAS PubMed Google Scholar
• Suit, H. D., Sedlacek, R. & Thames, H. D. in Rodent tumor models in experimental cancer therapy (ed. Kallman, R. F.) 138–148 (Pergamon Press, New York, 1987).
  Google Scholar